Abstract: A method includes receiving a first signal at a front-end module (FEM) comprising a power amplifier, the first signal indicating an increase in expected power or modulation, in response to receiving the first signal, increasing power at the power amplifier for one or more packets; and, after processing the one or more packets, reducing power at the power amplifier.

Abstract: A beverage dispenser maintains a profile queue with profile data of “close” consumer mobile computing devices. Each profile in the profile queue maintains one or more beverages previously selected by a consumer, such as favorite beverage(s), mixed or blended beverages, and/or past or future beverage order(s). Each profile in the profile queue is additionally associated with a profile identifier, such as a name, screen name, social media picture, avatar, alphanumeric identifier, other such text or graphics recognizable by a consumer to be associated with their corresponding profile. Upon navigation to an appropriate screen on the beverage dispenser, a display on the beverage dispenser shows the profile identifiers or one or more of the previously selected beverages in the profiles of “close” consumer mobile computing devices. In this way, a consumer is able to quickly access their previously selected beverages without actively manipulating their mobile device.

Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.

Abstract: A beverage dispenser and method for operating a beverage dispenser may include receiving a handshake request from a mobile device of a user. A communications link may be established with the mobile device. Responsive to receiving control data associated with a beverage order from the mobile device, a physical function may be caused to be performed by the beverage dispenser.

Abstract: A wall-mountable perch includes: a frame including: first horizontal side members; a first cross member connected to each of the first horizontal side members proximate to a respective distal end of each of the first horizontal side members; second horizontal side members connected to the first horizontal side members; a platform connected to the second horizontal side members; a plurality of support arms each having a proximal end connected proximate to a proximal end of the frame, each support arm extending vertically upward from the frame; tension arms each connected to a respective horizontal side member; and adjusting means for producing tension in the tension arms and for causing a second cross member of the wall-mountable perch to move closer to the platform.

Abstract: A wall-mountable perch includes: a frame including: first horizontal side members; a first cross member connected to each of the first horizontal side members proximate to a respective distal end of each of the first horizontal side members; second horizontal side members connected to the first horizontal side members; a platform connected to the second horizontal side members; a plurality of support arms each having a proximal end connected proximate to a proximal end of the frame, each support arm extending vertically upward from the frame and being configured to be flexible to bend along a respective length of each of the plurality of support arms; tension arms each connected to a respective horizontal side member; and adjusting means for producing tension in the tension arms and for causing a second cross member of the wall-mountable perch to move closer to the platform.

Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.

Abstract: Novel compounds, compositions, and methods of using and preparing the same, which maybe useful for treating alpha-1 antitrypsin deficiency (AATD).

Abstract: Novel compounds, compositions, and methods of using and preparing the same, which may be useful for treating alpha-1 antitrypsin deficiency (AATD).

Abstract: Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.

Abstract: Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD).

Abstract: Novel compounds, compositions, and methods of using and preparing the same, which may be useful for treating alpha-1 antitrypsin deficiency (AATD).

Abstract: A beverage dispenser and method for operating a beverage dispenser may include receiving a handshake request from a mobile device of a user. A communications link may be established with the mobile device. Responsive to receiving control data associated with a beverage order from the mobile device, a physical function may be caused to be performed by the beverage dispenser.

Abstract: Various aspects include devices, systems, and methods for multi-tank immersion cooling distribution. The devices and systems may include a coolant distribution unit, a coolant manifold, a supply and return line, and one or more immersion cooling racks. The coolant distribution unit may be configured to adjust a temperature and pump a fluid used as a coolant. The coolant manifold may redistribute the fluid. The immersion cooling racks may be disposed between the coolant distribution unit and the coolant manifold. Each immersion cooling rack may be coupled to the coolant manifold through an inlet duct for receiving the fluid from the coolant manifold and an outlet duct for returning the fluid to the coolant manifold.

Abstract: A beverage dispenser and method for operating a beverage dispenser may include receiving a handshake request from a mobile device of a user. A communications link may be established with the mobile device. Responsive to receiving control data associated with a beverage order from the mobile device, a physical function may be caused to be performed by the beverage dispenser.

Abstract: A beverage dispenser maintains a profile queue with profile data of “close” consumer mobile computing devices. Each profile in the profile queue maintains one or more beverages previously selected by a consumer, such as favorite beverage(s), mixed or blended beverages, and/or past or future beverage order(s). Each profile in the profile queue is additionally associated with a profile identifier, such as a name, screen name, social media picture, avatar, alphanumeric identifier, other such text or graphics recognizable by a consumer to be associated with their corresponding profile. Upon navigation to an appropriate screen on the beverage dispenser, a display on the beverage dispenser shows the profile identifiers or one or more of the previously selected beverages in the profiles of “close” consumer mobile computing devices. In this way, a consumer is able to quickly access their previously selected beverages without actively manipulating their mobile device.

Abstract: A method for producing a molded part, in particular a component of a sporting good, includes providing a mixture of a polymer melt and a foaming agent and injecting the mixture into a mold. The method includes solidifying at least a first portion of the molded part without foaming and at least a second portion of the molded part after foaming inside the mold, wherein the mixture includes a polymer having an average molecular mass corresponding to a viscosity number ?130 ml/g, preferably ?170 ml/g, more preferably ?190 ml/g and most preferably ?225 ml/g, wherein the viscosity number is determined via solution viscometry according to the ISO 307 standard.

Abstract: An improved chemical process for the manufacture of the compound of Formula (I), which is useful, for example, as a late-stage chemical intermediate in the production of osimertinib (AZD9291) and pharmaceutically acceptable salts thereof.